Doctor profile · Federal record
Dr. Carlos Decastro, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Durham, NC
- NPI 1912080169
- Accepts Medicare
- 41 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
Duke University Medical Ctr
Durham, NC 277100001
(919) 620-4467
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- August 13, 2013
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- North Carolina #33980
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1912080169. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
415
Distinct HCPCS
4
Medicare allowed
$44,780
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 229 | 111 | $91 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 86 | 20 | $114 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 80 | 43 | $133 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 20 | 20 | $172 |
In context: peer comparison
Among 18 peers in Durham Hematology & Oncology Physician, average services per provider: 351. This provider delivers 1.2× the peer median.Open Payments
Industry payments received
All-time total
$17,962
Transactions
15
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | 5 | $6,856.34 | |
| Alexion Pharmaceuticals, INC. | 2 | $5,440.00 | |
| Novartis Pharmaceuticals Corporation | 6 | $4,050.46 | |
| Genentech USA, INC. | 1 | $1,520.00 | |
| GlaxoSmithKline, LLC. | 1 | $94.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
220
Patients
0
Total drug cost
$1,762,203
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Imatinib Mesylate | Generic | 62 | 0 | $24,007 |
| Cyclosporine Modified (Cyclosporine, Modified) | Brand | 26 | 0 | $2,800 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 22 | 0 | $357,122 |
| Inqovi (Decitabine/Cedazuridine) | Brand | 20 | 0 | $155,813 |
| Prednisone | Generic | 18 | 0 | $93 |
| Tasigna (Nilotinib Hcl) | Brand | 18 | 0 | $263,689 |
| Methotrexate (Methotrexate Sodium) | Brand | 14 | 0 | $492 |
| Venclexta (Venetoclax) | Brand | 14 | 0 | $68,028 |
| Xospata (Gilteritinib Fumarate) | Brand | 14 | 0 | $331,293 |
| Empaveli (Pegcetacoplan) | Brand | 12 | 0 | $558,865 |
Frequently asked questions
What is Dr. Carlos Decastro's medical specialty?
Dr. Carlos Decastro practices Hematology & Oncology Physician in Durham, NC.
Where does Dr. Carlos Decastro practice?
Dr. Carlos Decastro practices at Duke University Medical Ctr, Durham, NC 277100001. Office phone: 9196204467.
What is Dr. Carlos Decastro's NPI?
Dr. Carlos Decastro's National Provider Identifier (NPI) is 1912080169, issued by NPPES.
Does Dr. Carlos Decastro accept Medicare assignment?
Yes. Dr. Carlos Decastro accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Carlos Decastro commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.